CBD delivered from Lexaria’s TurboCBDTM capsules was absorbed much more effectively than from the positive control, delivering 317% more CBD to blood at the 30-minute mark of the study.
A unique cannabis strain that has the capacity to inhibit dendritic-dependent T-cells proliferation has been identified by researchers in Israel.
Achieving ISO/IEC 17025 accreditation is the pinnacle in third-party laboratory accreditation.
The grant will fund a series of preclinical studies to determine whether THC consumption during adolescence causes persistent neurological changes.
The cannabis-derived compound could be used to treat nausea in cancer patients receiving chemotherapy.
Mice with pancreatic cancer that were treated with a naturally occurring constituent of medicinal cannabis alongside chemotherapy, survived almost three times longer than those treated with chemotherapy alone, a new study reports.
The team behind the research pointed at that the trial results may not be generalizable because the number of participants was small and only represented a group of patients with stable, but advanced, COPD
Results of a randomized, double-blind clinical trial suggest that nabilone may be effective in treating agitation in people with Alzheimer's disease.
Under current recommendations, people who use cannabis for conditions including chronic pain, arthritis, the side effects of chemotherapy and even the self-medication of brain and other tumours, will continue to be criminalised.